BHMP
AGN

Bardin Hill Management Partners’s Allergan plc AGN Stock Holding History

Bardin Hill Management Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-258
Closed -$287K – 119
2015
Q1 		$287K Buy
+258
New +$73.6K 0.04% 98

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Bardin Hill Management Partners's AGN Position: Q2 2020 in Review

Bardin Hill Management Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 253,299 shares — an estimated $44.9M sold.

Bardin Hill Management Partners first reported a position in AGN in Q1 2015 and held it in 6 quarters. The position peaked at $66.6M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bardin Hill Management Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bardin Hill Management Partners sold 253,299 Allergan plc shares in Q2 2020, an estimated $44.9M.
  • Bardin Hill Management Partners first reported a position in Allergan plc in Q1 2015 and held it in 6 quarters.
  • Bardin Hill Management Partners's Allergan plc position peaked at $66.6M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bardin Hill Management Partners's 13F filing for Q2 2020, filed 14 Aug 2020.